Clinical Trials Browser

Phase 2 × OTHER × margetuximab × Clear all

NCT04425018 2025-11-18

MARGOT

Phase 2 Active not recruiting

174 enrolled 19 charts

Breast Neoplasms

NCT05227131 2022-07-11

MARGARET

Phase 2 Withdrawn

Breast Neoplasms